The nigrostriatal system in the presymptomatic and symptomatic stages in the MPTP monkey model: a PET, histological and biochemical study
- PMID: 22677034
- DOI: 10.1016/j.nbd.2012.05.018
The nigrostriatal system in the presymptomatic and symptomatic stages in the MPTP monkey model: a PET, histological and biochemical study
Abstract
Parkinson's disease (PD) is diagnosed when striatal dopamine (DA) loss exceeds a certain threshold and the cardinal motor features become apparent. The presymptomatic compensatory mechanisms underlying the lack of motor manifestations despite progressive striatal depletion are not well understood. Most animal models of PD involve the induction of a severe dopaminergic deficit in an acute manner, which departs from the typical, chronic evolution of PD in humans. We have used 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) administered to monkeys via a slow intoxication protocol to produce a more gradual development of nigral lesion. Twelve control and 38 MPTP-intoxicated monkeys were divided into four groups. The latter included monkeys who were always asymptomatic, monkeys who recovered after showing mild parkinsonian signs, and monkeys with stable, moderate and severe parkinsonism. We found a close correlation between cell loss in the substantia nigra pars compacta (SNc) and striatal dopaminergic depletion and the four motor states. There was an overall negative correlation between the degree of parkinsonism (Kurlan scale) and in vivo PET ((18)F-DOPA K(i) and (11)C-DTBZ binding potential), as well as with TH-immunoreactive cell counts in SNc, striatal dopaminergic markers (TH, DAT and VMAT2) and striatal DA concentration. This intoxication protocol permits to establish a critical threshold of SNc cell loss and dopaminergic innervation distinguishing between the asymptomatic and symptomatic parkinsonian stages. Compensatory changes in nigrostriatal dopaminergic activity occurred in the recovered and parkinsonian monkeys when DA depletion was at least 88% of control, and accordingly may be considered too late to explain compensatory mechanisms in the early asymptomatic period. Our findings suggest the need for further exploration of the role of non-striatal mechanisms in PD prior to the development of motor features.
Copyright © 2012 Elsevier Inc. All rights reserved.
Similar articles
-
In vivo measures of nigrostriatal neuronal response to unilateral MPTP treatment.Brain Res. 2014 Jul 7;1571:49-60. doi: 10.1016/j.brainres.2014.05.009. Epub 2014 May 15. Brain Res. 2014. PMID: 24845719 Free PMC article.
-
Levodopa induces long-lasting modification in the functional activity of the nigrostriatal pathway.Neurobiol Dis. 2014 Feb;62:250-9. doi: 10.1016/j.nbd.2013.09.014. Epub 2013 Sep 27. Neurobiol Dis. 2014. PMID: 24076099
-
Intervention with exercise restores motor deficits but not nigrostriatal loss in a progressive MPTP mouse model of Parkinson's disease.Neuroscience. 2015 Jul 23;299:156-74. doi: 10.1016/j.neuroscience.2015.04.069. Epub 2015 May 2. Neuroscience. 2015. PMID: 25943481
-
Time-course of nigrostriatal degeneration in a progressive MPTP-lesioned macaque model of Parkinson's disease.Mol Neurobiol. 2003 Dec;28(3):209-18. doi: 10.1385/MN:28:3:209. Mol Neurobiol. 2003. PMID: 14709785 Review.
-
Chronic MPTP administration regimen in monkeys: a model of dopaminergic and non-dopaminergic cell loss in Parkinson's disease.J Neural Transm (Vienna). 2018 Mar;125(3):337-363. doi: 10.1007/s00702-017-1774-z. Epub 2017 Aug 31. J Neural Transm (Vienna). 2018. PMID: 28861737 Free PMC article. Review.
Cited by
-
Dopamine Signaling in Substantia Nigra and Its Impact on Locomotor Function-Not a New Concept, but Neglected Reality.Int J Mol Sci. 2024 Jan 17;25(2):1131. doi: 10.3390/ijms25021131. Int J Mol Sci. 2024. PMID: 38256204 Free PMC article. Review.
-
Motor and non-motor circuit disturbances in early Parkinson disease: which happens first?Nat Rev Neurosci. 2022 Feb;23(2):115-128. doi: 10.1038/s41583-021-00542-9. Epub 2021 Dec 14. Nat Rev Neurosci. 2022. PMID: 34907352 Review.
-
An adverse outcome pathway for parkinsonian motor deficits associated with mitochondrial complex I inhibition.Arch Toxicol. 2018 Jan;92(1):41-82. doi: 10.1007/s00204-017-2133-4. Epub 2017 Dec 5. Arch Toxicol. 2018. PMID: 29209747 Free PMC article. Review.
-
Application of the Physical Disector Principle for Quantification of Dopaminergic Neuronal Loss in a Rat 6-Hydroxydopamine Nigral Lesion Model of Parkinson's Disease.Front Neuroanat. 2017 Dec 8;11:109. doi: 10.3389/fnana.2017.00109. eCollection 2017. Front Neuroanat. 2017. PMID: 29276478 Free PMC article.
-
Imaging Dopamine and Serotonin Systems on MPTP Monkeys: A Longitudinal PET Investigation of Compensatory Mechanisms.J Neurosci. 2016 Feb 3;36(5):1577-89. doi: 10.1523/JNEUROSCI.2010-15.2016. J Neurosci. 2016. PMID: 26843639 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Miscellaneous